Profiel
Rodger Novak richtte CRISPR Therapeutics AG en Nabriva Therapeutics GmbH op. Momenteel bekleedt Dr. Novak de positie van Chairman & President van CRISPR Therapeutics AG. In het verleden was hij Global Head-Anti Infectives Research & Development bij Sanofi Pharma SA, Chief Operating Officer voor Nabriva Therapeutics GmbH, Head-Scientific & Medical Affairs bij het Antibiotic Research Institute, Deputy Head-Antibiotic Research Institute bij Sandoz AG, Deputy Head-Antibiotic Research Institute bij Sandoz GmbH en Professor-Microbiology bij het Vienna Biocenter. Rodger Novak promoveerde aan de Philipps Universiteit van Marburg.
Actieve functies van Rodger Novak
| Bedrijven | Functie | Begin |
|---|---|---|
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 01-10-2020 |
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Directeur/Bestuurslid | 01-01-2014 |
Airna, Inc.
Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Directeur/Bestuurslid | - |
Xap Therapeutics Ltd
Xap Therapeutics Ltd Pharmaceuticals: MajorHealth Technology Develops multi-modal therapies to treat complex diseases: cancer and autoimmunity | Oprichter | - |
Eerdere bekende functies van Rodger Novak
| Bedrijven | Functie | Einde |
|---|---|---|
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 01-01-2025 |
| CRISPR THERAPEUTICS AG | Algemeen Directeur | 01-12-2017 |
Sanofi AG | Corporate Officer/Principal | 01-11-2013 |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Corporate Officer/Principal | 01-12-2005 |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Oprichter | - |
Opleiding van Rodger Novak
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 14 |
|---|---|
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
Antibiotic Research Institute
Antibiotic Research Institute Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research | Commercial Services |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz GmbH
Sandoz GmbH Pharmaceuticals: MajorHealth Technology Manufactures generic pharmaceuticals and biotechnological drugs | Health Technology |
Sanofi AG | |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Vienna Biocenter
Vienna Biocenter Miscellaneous Commercial ServicesCommercial Services Operates biology research center | Commercial Services |
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Xap Therapeutics Ltd
Xap Therapeutics Ltd Pharmaceuticals: MajorHealth Technology Develops multi-modal therapies to treat complex diseases: cancer and autoimmunity | Health Technology |
Airna, Inc.
Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Commercial Services |
















